SG11202012984YA - STABILITY OF VITAMIN D IN ß-HYDROXY- ß-METHYLBUTYRATE (HMB) - Google Patents
STABILITY OF VITAMIN D IN ß-HYDROXY- ß-METHYLBUTYRATE (HMB)Info
- Publication number
- SG11202012984YA SG11202012984YA SG11202012984YA SG11202012984YA SG11202012984YA SG 11202012984Y A SG11202012984Y A SG 11202012984YA SG 11202012984Y A SG11202012984Y A SG 11202012984YA SG 11202012984Y A SG11202012984Y A SG 11202012984YA SG 11202012984Y A SG11202012984Y A SG 11202012984YA
- Authority
- SG
- Singapore
- Prior art keywords
- hmb
- methylbutyrate
- vitamin
- hydroxy
- stability
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2019/038948 WO2020263229A1 (en) | 2019-06-25 | 2019-06-25 | STABILITY OF VITAMIN D IN β-HYDROXY- β-METHYLBUTYRATE (HMB) |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202012984YA true SG11202012984YA (en) | 2021-01-28 |
Family
ID=74060572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202012984YA SG11202012984YA (en) | 2019-06-25 | 2019-06-25 | STABILITY OF VITAMIN D IN ß-HYDROXY- ß-METHYLBUTYRATE (HMB) |
Country Status (7)
Country | Link |
---|---|
JP (1) | JP2022545299A (zh) |
KR (1) | KR20220050082A (zh) |
CN (1) | CN113056206A (zh) |
AU (1) | AU2019453386A1 (zh) |
CA (1) | CA3105039A1 (zh) |
SG (1) | SG11202012984YA (zh) |
WO (1) | WO2020263229A1 (zh) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6849613B2 (en) * | 2001-08-29 | 2005-02-01 | Kedar N. Prasad | Multiple antioxidant micronutrients |
US20060019933A1 (en) * | 2004-07-22 | 2006-01-26 | David Boardman | Process for preparing stabilized vitamin D |
US20100178369A1 (en) * | 2009-01-15 | 2010-07-15 | Nicole Lee Arledge | Antioxidant-stabilized concentrated fish oil |
SG192692A1 (en) * | 2011-02-07 | 2013-09-30 | Abbott Lab | Nutritional products comprising beta-hydroxy-beta-methylbutyrate |
CN102512655B (zh) * | 2011-11-30 | 2013-10-30 | 北京康比特体育科技股份有限公司 | 左旋肉碱组合物和制剂,及其制备方法和应用 |
JP6480964B2 (ja) * | 2014-03-14 | 2019-03-13 | メタボリック・テクノロジーズ,インコーポレーテッド | 遊離酸形のβ−ヒドロキシ−β−メチル酪酸(HMB)を含有する液体及び食品ならびにその製造法 |
CN109862875A (zh) * | 2016-03-30 | 2019-06-07 | 西姆莱斯股份公司 | 一种活性混合物 |
-
2019
- 2019-06-25 WO PCT/US2019/038948 patent/WO2020263229A1/en unknown
- 2019-06-25 CN CN201980057166.8A patent/CN113056206A/zh active Pending
- 2019-06-25 AU AU2019453386A patent/AU2019453386A1/en active Pending
- 2019-06-25 CA CA3105039A patent/CA3105039A1/en active Pending
- 2019-06-25 SG SG11202012984YA patent/SG11202012984YA/en unknown
- 2019-06-25 KR KR1020217010076A patent/KR20220050082A/ko active Search and Examination
- 2019-06-25 JP JP2020572417A patent/JP2022545299A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2019453386A1 (en) | 2021-02-18 |
JP2022545299A (ja) | 2022-10-27 |
KR20220050082A (ko) | 2022-04-22 |
WO2020263229A1 (en) | 2020-12-30 |
CA3105039A1 (en) | 2020-12-30 |
CN113056206A (zh) | 2021-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL283743A (en) | History of 2-Oxoquinazoline as Methionine Adenosyl Transferase 2a Inhibitors | |
ZA201907661B (en) | Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor | |
IL262495B (en) | History of isoquinolin-3-yl carboxamide and pharmaceutical preparations containing them | |
GB201806953D0 (en) | Cannabidiol Preparations | |
SG11202102456VA (en) | High-potency vitamin c topical formulations | |
EP3344624B8 (en) | Tyk2 inhibitors and uses thereof | |
EP3262049A4 (en) | Tyk2 inhibitors and uses thereof | |
GEP20207075B (en) | New aminoacid derivatives, a process for their preparation and pharmaceutical compositions containing them | |
IL267831A (en) | Substances used for healing and as nutritional supplements | |
ZA201801651B (en) | Application of high flavonoid elite germplasm 'csr6r6-777' in breeding for functional apple | |
PL3139904T3 (pl) | Formulacja witaminy rozpuszczalnej w tłuszczach | |
EP3731832A4 (en) | CANNABINOID DOSAGE FORM | |
EP3472176A4 (en) | THE USEFULNESS OF (+) EPICATECHIN AND THEIR ANALOGS | |
IL268072A (en) | Methods and systems for improving the stability of electronic inhaler pre-vapor formulations | |
EP3380525A4 (en) | PHARMACEUTICAL FORMULATIONS AND METHODS OF USE | |
HK1252405A1 (zh) | 用於減少脂肪量的β-羥基-β-甲基丁酸(HMB)的組合物和使用方法 | |
IL285674A (en) | Pharmaceutical formulations | |
IL269305A (en) | Cannabinoid formulations and dosage | |
CA200923S (en) | Footrest | |
EP3285768A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH LONAFARNIB AND RITONAVIR | |
EP3506947A4 (en) | PHARMACEUTICAL FORMULATIONS OF REGADENOSONE | |
SG11202012984YA (en) | STABILITY OF VITAMIN D IN ß-HYDROXY- ß-METHYLBUTYRATE (HMB) | |
EP3612185A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH POH DERIVATIVES AND METHODS OF APPLICATION | |
EP3554508A4 (en) | SUVOREXANT PHARMACEUTICAL FORMULATIONS | |
EP3836803A4 (en) | STABILITY OF VITAMIN D IN BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) |